Several retrospective studies describe a reduction in C-reactive protein (CRP)-levels after EPA supplementation, however evidence in cancer patients is ambiguous as increased inflammatory markers could also be caused by increased cell damage [37,50]. The gene discussed is CRP; the disease is cancer.